FAFSA deadline approaching, students urged to seek aid now
The FAFSA, or Free Application for Federal Student Aid, must be submitted by the end of the month. The application is the first step to accessing billions of dollars in financial aid.
'FAFSA unlocks federal grants, loans, and work-study as well as many state and college programs' aid on a first-come, first-served basis,' Shaan Patel, Founder and CEO of PrepExpert.com, an online college prep service, said.
The entire application can be completed online.
'Make sure you have all your necessary documents… so you get the maximum financial aid possible for college this fall,' Patel said.
Dr. Rhea Watson, also known as The Scholarship Doctor and CEO of Scholarship Solutions, warns that skipping the FAFSA could cost you thousands of dollars. She emphasizes that it's a mistake to assume you won't qualify for financial aid.
'If you don't have a FAFSA application on file, it is nearly impossible, very difficult for your scholarship applications and even those financial aid packages you want to receive from a college,' Watson said.
Roughly $3 billion in aid goes unclaimed every year, Watson said.
'Don't leave money on the table… it just goes and recycles through the government versus going to students who can use it to go to school and go without debt,' Watson said.
The FAFSA only takes a few hours to complete if one is prepared. Once submitted, one can expect the financial aid award letter within 2 to 3 weeks. However, keep in mind that state and school-specific aid can run out quickly, so it's best to apply as early as possible.
Documents needed for filling out the FAFSA include:
Social Security number
Parents' Social Security numbers (if you are a dependent student)
Tax returns
Records of child support received
Current balances of cash, savings, and checking accounts
Social Security card, driver's license, and/or alien registration card (if not a US citizen)
Federal income tax returns, W-2s, and other records of money earned
For more information on what students need to know before they fill out the FAFSA form, click here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Chicago Tribune
15 minutes ago
- Chicago Tribune
President Donald Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not
WASHINGTON — President Donald Trump keeps saying that Republicans' mega tax and spending cut legislation will eliminate taxes on federal Social Security benefits. It does not. At best, Trump's 'no tax on Social Security' claim exaggerates the benefits to seniors if either the House or Senate-passed proposals is signed into law. Here's a look at Trump's recent statements, and what the proposals would — or would not — do. Trump repeatedly told voters during his 2024 campaign that he would eliminate taxes on Social Security. As his massive legislative package has moved through Congress, the Republican president has claimed that's what the bill would do. Trump said on a recent appearance on Fox News' 'Sunday Morning Futures' that the bill includes 'no tax on tips, no tax on Social Security, no tax on overtime.' But instead of eliminating the tax, the Senate and House have each passed their own versions of a temporary tax deduction for seniors aged 65 and over, which applies to all income — not just Social Security. And it turns out not all Social Security beneficiaries will be able to claim the deduction. Those who won't be able to do so include the lowest-income seniors who already don't pay taxes on Social Security, those who choose to claim their benefits before they reach age 65 and those above a defined income threshold. The Senate proposal includes a temporary $6,000 deduction for seniors over the age of 65, contrasted with the House proposal, which includes a temporary deduction of $4,000. The Senate proposal approved Tuesday would eliminate Social Security tax liability for seniors with adjusted gross incomes of $75,000 or less or $150,000 if filing as a married couple. If passed into law, the tax deduction would last four years, from 2025 to 2029. The deductions phase out as income increases. Touting a new Council of Economic Advisers analysis, the White House said Tuesday that '88% of all seniors who receive Social Security — will pay NO TAX on their Social Security benefits,' going on to say that the Senate proposal's $6,000 senior deduction 'is estimated to benefit 33.9 million seniors, including seniors not claiming Social Security. The deduction yields an average increase in after-tax income of $670 per senior who benefits from it.' Garrett Watson, director of policy analysis at the Tax Foundation think tank, said conflating the tax deduction with a claim that there will be no tax on Social Security could end up confusing and angering a lot of seniors who will expect to not pay taxes on their Social Security benefits. 'While the deduction does provide some relief for seniors, it's far from completely repealing the tax on their benefits,' Watson said. The cost of actually eliminating the tax on Social Security would have massive impacts on the economy. University of Pennsylvania's Penn Wharton Budget Model estimates that eliminating income taxes on Social Security benefits 'would reduce revenues by $1.5 trillion over 10 years and increase federal debt by 7 percent by 2054″ and speed up the projected depletion date of the Social Security Trust Fund from 2034 to 2032. Discussions over taxes on Social Security are just part of the overall bill, which is estimated in its Senate version to increase federal deficits over the next 10 years by nearly $3.3 trillion from 2025 to 2034, according to the Congressional Budget Office. Administration officials have said the cost of the tax bill would be offset by tariff income. Recently, the CBO separately estimated that Trump's sweeping tariff plan would cut deficits by $2.8 trillion over a 10-year period while shrinking the economy, raising the inflation rate and reducing the purchasing power of households overall.
Business Wire
28 minutes ago
- Business Wire
Knightscope Secures Another $1M in New Sales, Renewals & Expansions;
SUNNYVALE, Calif.--(BUSINESS WIRE)-- Knightscope, Inc. (NASDAQ: KSCP), a leader in developing autonomous security robots and artificial intelligence technologies, today announced over $1 million in newly secured contracts that span major client renewals, strategic expansions, and new wins across the country. The increase reflects a continuing demand for smarter, safer environments and is underscored by ongoing interest, including on Capitol Hill. Emergency Communication Devices Grow Across the Nation Knightscope locked in major new wins in the higher education, parks & recreation, healthcare, and local government sectors with an impressive 541 brand-new Emergency Communication Devices (ECDs) bookings. This wave of new contracts highlights the widespread trust in Knightscope's life-saving communication technology. Robots on Patrol: ASRs Hit New Markets Knightscope's Autonomous Security Robots (ASRs) are on the move. New K5 contracts are rolling out in the Transit Authority, Data Center, and Higher Education sectors, reinforcing its growing presence across critical infrastructure and public spaces. Highlights at a Glance Public Sector Power – Cities, states and law enforcement agencies are doubling down with expanded ECD purchases and extended Full-Service Maintenance (FSM) agreements. Renewals Signal Results – Eight (8) ASR subscriptions were renewed across key sectors, including retail, biotech, and hospitality, proving Knightscope's staying power and performance. Capitol Hill Knightscope continues to gain meaningful traction in Washington, D.C. Following recent visits that included dozens of engagements with public officials and stakeholders, the Company has been invited back for a hearing on certain technologies to occur in July. About Knightscope Knightscope is transforming public safety with cutting-edge robotics and AI technologies. From autonomous security robots to advanced detection systems, Knightscope is committed to building safer communities where you live, work, study and visit. Our long-term ambition is bold but simple: to make the United States of America the safest country in the world. Learn more about us at Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as "should," "may," "intends," "anticipates," "believes," "estimates," "projects," "forecasts," "expects," "plans," "proposes" and similar expressions. Forward-looking statements contained in this press release and other communications include, but are not limited to, statements about the Company's goals, profitability, growth, prospects, reduction of expenses, and outlook. Although Knightscope believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks, uncertainties and other important factors that could cause actual results to differ materially from such forward-looking statements, including the factors discussed under the heading "Risk Factors" in Knightscope's Annual Report on Form 10-K for the year ended December 31, 2024, as updated by its other filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date of the document in which they are contained, and Knightscope does not undertake any duty to update any forward-looking statements, except as may be required by law.
Yahoo
32 minutes ago
- Yahoo
Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.
PEACHTREE CORNERS, Ga., July 02, 2025--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that on June 27th that it made its first shipment of devices and single use components to Hangzhou Dongye Medical Technology Company, Ltd. (HDMT). This order is in addition to future shipments connected with a separate $700,000 purchase order executed earlier this year between HDMT and GTHP. Based on the June 27th shipment, GTHP will recognize an additional $117,462 in sales revenue for the second quarter of 2025. The first three devices from the new $700,000 order have been manufactured and tested, triggering a $70,000 payment from HDMT expected in July 2025. HDMT is in Hangzhou City, Zhejiang Province, where it is the exclusive provider of gynecology products for 42 hospitals that perform approximately two million cervical cancer screenings annually. About Guided Therapeutics Guided Therapeutics, Inc. (OTCQB: GTHP) is the maker of a rapid and painless testing platform based on its patented biophotonic technology that utilizes light for the early detection of disease at the cellular level. The Company's first product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial with women at risk for cervical disease, the technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. For more information, visit: The Guided Therapeutics LuViva® Advanced Cervical Scan is an investigational device and is limited by federal law to investigational use in the U.S. LuViva, the wave logo and "Early detection, better outcomes" are registered trademarks owned by Guided Therapeutics, Inc. Forward-Looking Statements Disclaimer: A number of the matters and subject areas discussed in this news release that are not historical or current facts deal with potential future circumstances and developments. The discussion of such matters and subject areas is qualified by the inherent risks and uncertainties surrounding future expectations generally and also may materially differ from Guided Therapeutics' actual future experience involving any of or more of such matters and subject areas. Such risks and uncertainties include those related to the early stage of commercialization of products, the uncertainty of market acceptance of products, the uncertainty of development or effectiveness of distribution channels, the intense competition in the medical device industry, the sufficiency of capital raised in prior financings and the ability to realize their expected benefits, the uncertainty of future capital to develop products or continue as a going concern, the uncertainty of regulatory approval of products, and the dependence on licensed intellectual property, as well as those that are more fully described from time to time under the heading "Risk Factors" in Guided Therapeutics' reports filed with the SEC, including Guided Therapeutics' Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and subsequent filings. View source version on Contacts Mark FaupelGuided Therapeutics770-242-8723 Sign in to access your portfolio
